ArticleVaccines2022

Safety of Vaccines against SARS-CoV-2 among Polish Patients with Multiple Sclerosis Treated with Disease-Modifying Therapies.

Agata Czarnowska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.